As per Market Research Future analysis, the global dry ice market size was estimated at approximately USD 1.63 million in 2024 and is projected to grow from USD 1.8 million in 2025 to USD 4.0 million by 2035, exhibiting a CAGR of 8.56% during the forecast period 2025–2035. The pharmaceutical sector is emerging as a major contributor to this growth due to increasing demand for temperature-controlled logistics.

A critical factor supporting this expansion is the rising need for pharmaceutical cold chain logistics market growth. Dry ice is essential in maintaining ultra-low temperatures required for transporting vaccines, biologics, and clinical trial materials. Its non-toxic nature and ability to sublimate without leaving residue make it highly suitable for sensitive pharmaceutical applications.

The global expansion of healthcare infrastructure and pharmaceutical manufacturing is boosting demand for reliable cold chain solutions. The distribution of vaccines and temperature-sensitive drugs requires consistent temperature maintenance, which dry ice effectively provides. This has become particularly important with the increasing focus on global immunization programs.

Technological advancements in packaging are enhancing the efficiency of dry ice usage in pharmaceuticals. Advanced insulated containers and temperature-monitoring systems ensure product safety during transportation. These innovations are reducing product loss and improving supply chain reliability.

Additionally, regulatory compliance is driving the adoption of dry ice. Pharmaceutical companies must adhere to strict guidelines for transporting sensitive products, and dry ice meets these standards effectively. Its widespread acceptance in regulatory frameworks further supports market growth.

However, challenges such as safety concerns and handling complexities must be addressed. Dry ice requires proper ventilation and handling procedures to prevent risks associated with carbon dioxide buildup.

In conclusion, the pharmaceutical sector is a key driver of the dry ice market, with increasing demand for cold chain logistics and advanced packaging solutions supporting long-term growth.

GLOBAL SUPPLY CHAIN & MARKET DISRUPTION ALERT
Escalating geopolitical tensions in the Middle East, particularly around the Strait of Hormuz and the Red Sea, are creating significant disruptions across global energy, chemicals, and logistics markets. Critical shipping corridors are under pressure, with major oil, LNG, petrochemical, and raw material flows at risk, triggering supply chain delays, freight cost surges, insurance withdrawals, and heightened price volatility. These disruptions are increasing operational risks and cost uncertainties for industries dependent on global trade routes and energy-linked feedstocks.
Access our real-time disruption analysis covering supply chain risks, price outlook scenarios, logistics impacts, and alternative sourcing strategies.

👉 Request a Sample Report to understand the potential impact on your industry and get actionable insights to support procurement, risk management, and supply chain planning.
Contact us today to receive the latest market intelligence and mitigation strategies.

FAQs:
Q1: Why is dry ice used in pharmaceuticals?
A1: It maintains ultra-low temperatures for sensitive products.

Q2: What products require dry ice in healthcare?
A2: Vaccines, biologics, and clinical samples.

Q3: What are the safety concerns?
A3: Improper handling can cause carbon dioxide buildup.